Pag Biopharmaceuticals-B (02565.HK) plans to globally issue 19.2835 million shares and introduce Yize Kangrui as a cornerstone investor.

Wisdom Finance APP news, Pacific Pharmaceuticals-B (02565.HK) will be listed for IPO from May 19 to May 22, 2025, intending to globally offer 19.2835 million shares, with 10% for public offering in Hong Kong and 90% for international offering. The offer price will be HK$15.60 per share, with a minimum subscription of 500 shares per lot. It is expected that the H shares will be listed on May 27, 2025.